POEMS Syndrome

13 registered clinical trials studyying POEMS Syndrome — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS NCT07448935	Fondazione IRCCS Policlinico San Matteo di Pavia	—
Not Yet Recruiting	BCMA/CD3 BsAb Therapy for POEMS Syndrome NCT07115654	Institute of Hematology & Blood Diseases Hospital, China	Phase 2
Not Yet Recruiting	A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome NCT06518876	Novatim Immune Therapeutics (Zhejiang) Co., Ltd.	Phase 1
Recruiting	Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study NCT06040567	Rigshospitalet, Denmark	—
Unknown	To Evaluate Efficacy of Red Dichromatic Imaging (RDI) in Achieving Hemostasis During POEM Using GF 1500 UGI Sc NCT05476458	Asian Institute of Gastroenterology, India	—
Unknown	A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmu NCT05263817	Zhejiang University	EARLY_Phase 1
Recruiting	Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the N NCT04561557	Tongji Hospital	EARLY_Phase 1
Completed	Treatment of POEMS Syndrome With Daratumumab NCT04396496	University of Arkansas	Phase 2
Completed	Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome NCT02921893	Mayo Clinic	EARLY_Phase 1
Completed	Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial NCT02193698	Chiba University	Phase 2
Completed	Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome NCT01816620	Peking Union Medical College Hospital	Phase 2
Completed	POEMS Syndrome Treatment With Lenalidomide NCT01639898	University Hospital, Limoges	Phase 2
Unknown	The Treatment of Lenalidomide in Patients With POEMS Syndrome NCT00971685	Istituto Clinico Humanitas	Phase 2